Details

Autor(en) / Beteiligte

• Sun, Ai-Xue
• Cheng, Zhi-Li
• Wu, Pan-Pan
• Sheng, Yue-Hong
• Qu, Xiu-Juan
• Lu, Wen
• Zhao, Cheng-Gong
• Qian, Guo-Jun

Titel

Clinical outcome of medium-sized hepatocellular carcinoma treated with microwave ablation

Ist Teil von

• World journal of gastroenterology : WJG, 2015-03, Vol.21 (10), p.2997-3004

Ort / Verlag

United States: Baishideng Publishing Group Inc

Erscheinungsjahr

2015

Link zum Volltext

Quelle

Elektronische Zeitschriftenbibliothek - Freely accessible e-journals

Beschreibungen/Notizen

• AIM:To evaluate the outcomes of patients withmedium-sized hepatocellular carcinoma(HCC)who underwent percutaneous microwave ablation(MWA).METHODS:We retrospectively reviewed all patients with a single medium-sized HCC who underwent percutaneous MWA from January 2010 to January2013.Technical success,technical effectiveness and complications were subsequently observed.Survival curves were constructed using the Kaplan-Meier method.The Cox proportional hazards model was fitted to each variable.The relative prognostic significance o f t h e va r i a b l e s fo r p re d i c t i n g ove ra l l s u r v i va l rate,recurrence-free survival rate and local tumor recurrence(s)was assessed using univariate analysis.All variables with a P value<0.20 were subjected to multivariate analysis.RESULTS:The study included 182 patients(mean age,58 years;age range:22-86 years)with a single HCC(mean size,3.72±0.54 cm;range:3.02-5.00cm).The estimated technical effectiveness rate was93%in 182 patients.The major complication rate was2.7%(5/182),including liver abscess in 4 cases,and abdominal bleeding at the puncture site in 1 case.Thirty-day mortality rate was 0.5%(1/182).One patient died due to liver abscess-related septicemia.Cumulative recurrence-free survival and overall survival(OS)rates were 51%,36%,27%and 89%,74%,60%at 1,2,and 3 years,respectively.Age(P=0.017)and tumor diameter(P=0.029)were independent factors associated with local tumor recurrence.None of the factors had a statistically significant impact on recurrence-free survival.Serum albumin level(P=0.009)and new lesion(s)(P=0.029)were independently associated with OS.CONCLUSION:Percutaneous MWA is a relatively safe and effective treatment for patients with medium-sized HCC.